Ayd, who advanced thorazine use, dies

Mar 24, 2008

Dr. Frank Ayd Jr., a pioneer in the field of psychopharmacology, has died in Baltimore from complications of coronary artery disease at age 87.

Ayd, who died Monday, was a psychiatrist who studied his patients' responses to anti-psychotic and anti-depressant drugs, leading to influential clinical results, The New York Times reported.

In 1955, he reported to the American Psychiatric Association that using two anti-psychotic drugs -- chlorpromazine, better known as Thorazine and reserpine -- to treat schizophrenia usually meant patients could be treated in a general hospital or nursing home.

Ayd began giving Thorazine to delusional patients in 1952.

"He was one of the founding fathers of psychopharmacology in this country," Dr. Robert Findling, director of child and adolescent psychiatry at Case Western Reserve University, told the Times Thursday. "He was there at its inception as a scientific area of focused research."

His "Ayd's Lexicon of Psychiatry, Neurology and the Neurosciences" is a standard reference in the field, the Times said.

He helped start the Collegium Internationale Neuro-Psychopharmacology and the American College of Neuropsychopharmacology, and founded what became Psychopharm Review.

Ayd is survived by his wife, five sons, seven daughters, two sisters, a brother, 32 grandchildren and 38 great-grandchildren.

Copyright 2008 by United Press International

Explore further: For sporting greats, knowing when to quit is the hardest challenge of all

Related Stories

The discovery of the molecule Si-C-Si in space

16 minutes ago

The space between stars is not empty—it contains a vast reservoir of diffuse material with about 5-10% of the total mass of our Milky Way galaxy. Most of the material is gas, but about 1% of this mass (quite ...

Engineers tending to Cameroon's power grid

16 minutes ago

EPFL has teamed up with Swiss and Cameroonian partners to address major issues like stabilizing the country's existing grid, improving energy efficiency and developing hydroelectric potential.

Recommended for you

Smithsonian to improve ethics policies on research funding

Jun 26, 2015

After revelations that a scientist failed to disclose his funding sources for climate change research, the Smithsonian Institution said Friday it is improving its ethics and disclosure policies to avoid conflicts of interest.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.